Testing a drug for enlarged prostate symptoms
Treatments studied
Part of Kidney & urinary clinical trials.
This trial tests whether a drug called adalimumab (a TNF blocker) can improve symptoms of an enlarged prostate. It is for men aged 45-80 with a large prostate and bothersome urinary symptoms who have not used this type of medication before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 45 and 80 years old
- A doctor has diagnosed you with an enlarged prostate (BPH)
- Your prostate is at least 60 mL in size (checked by ultrasound or MRI)
- You have moderate to severe urinary symptoms (score of 8 or higher on a standard questionnaire)
- You have not taken a TNF blocker drug (like adalimumab, etanercept, or infliximab) before
- You do not have any of the following: active infection, tuberculosis, hepatitis B, cancer, or an autoimmune disease (like rheumatoid arthritis or Crohn's)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a better way to manage benign prostatic hyperplasia (BPH) by using your answers to regular health questionnaires. It may help your care team make more informed decisions about your symptoms and treatment over time.
This trial studies whether taking anti-inflammatory medicine (ibuprofen or similar “NSAID” drugs) can improve what doctors learn in people whose PSA blood test is higher than expected and who need more prostate testing. It may help reduce unnecessary procedures or improve next-step decisions, but only if you meet safety and eligibility rules.
This trial tests a new device designed to treat symptoms of an enlarged prostate (BPH), such as frequent or difficult urination. It may help improve urine flow and reduce discomfort without traditional surgery.
This trial tests new treatment strategies for benign prostatic hyperplasia (BPH, an enlarged prostate) using a special MRI scan and a medication called finasteride. It aims to find better ways to manage symptoms and identify markers that predict response.
This study tests a new medication (called DNN.65.21.005) for men with an enlarged prostate (also called benign prostatic hyperplasia, or BPH) who have bothersome urinary symptoms. The goal is to see if this medication safely relieves symptoms like frequent or difficult urination.
This trial tests whether combining two medicines works better than one alone for easing urinary symptoms caused by an enlarged prostate. If you have bothersome symptoms and a larger prostate, this study may help you find a more effective treatment.
Hear when a new Benign Prostatic Hyperplasia (BPH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.